1.
Stem Cells Dev
; 29(5): 257-262, 2020 03 01.
Article
in English
| MEDLINE
| ID: mdl-31797749
ABSTRACT
Although adipose tissue and cells show considerable promise for clinical translation in the emerging field of regenerative medicine, they present a challenge to the regulatory community both nationally and internationally. This commentary evaluates the status of adipose-derived therapeutics and considers regulatory approaches designed to maximize patient safety while advancing clinical translation in accordance with evidence-based medical science.